Michael Richard Feldschuh net worth and biography

Michael Feldschuh Biography and Net Worth

President & Chief Executive Officer of Daxor

Michael has held the position of president and CEO of Daxor Corporation since 2017. Prior to this, he served as a member of the board of directors before joining Daxor’s executive team in December of 2014. Michael has over 25 years of experience on Wall Street and in the medical field. He served as a managing director and portfolio manager for Morgan Stanley for six years and a managing director of Millennium Partners for eight years in addition to leading his own hedge fund, Aristarc Capital, from 2009 to 2013. Michael began his career at D.E. Shaw & Co. in New York, where he worked with Jeffery Bezos prior to Bezos’s founding of Amazon. Michael earned his bachelor’s degree in pre-med studies at Columbia College, Columbia University in 1991. Michael’s interests include photography and travel.

What is Michael Richard Feldschuh's net worth?: The estimated net worth of Michael Richard Feldschuh is at least $2.39 million as of April 8th, 2026. Mr. Feldschuh owns 213,694 shares of Daxor stock worth more than $2,389,099 as of September 22nd. This net worth approximation does not reflect any other assets that Mr. Feldschuh may own. Learn More about Michael Richard Feldschuh's net worth.
How do I contact Michael Richard Feldschuh?: The corporate mailing address for Mr. Feldschuh and other Daxor executives is 350 Fifth Avenue, Suite 7120, New York, NY, 10118. Daxor can also be reached via phone at 212-244-0555 and via email at [email protected]. Learn More on Michael Richard Feldschuh's contact information.
Has Michael Richard Feldschuh been buying or selling shares of Daxor?: Michael Richard Feldschuh has not been actively trading shares of Daxor during the past quarter. Most recently, on Wednesday, April 8th, Michael Richard Feldschuh bought 1,000 shares of Daxor stock. The stock was acquired at an average cost of $9.07 per share, with a total value of $9,070.00. Following the completion of the transaction, the chief executive officer now directly owns 213,694 shares of the company's stock, valued at $1,938,204.58. Learn More on Michael Richard Feldschuh's trading history.
Are insiders buying or selling shares of Daxor?: In the last twelve months, Daxor insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $9,070.00. The most recent insider tranaction occured on April, 8th when CEO Michael Richard Feldschuh bought 1,000 shares worth more than $9,070.00. Insiders at Daxor own 51.5% of the company. Learn More about insider trades at Daxor.
Information on this page was last updated on 4/8/2026.

Michael Richard Feldschuh Insider Trading History at Daxor

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/8/2026	Buy	1,000	$9.07	$9,070.00	213,694
4/4/2025	Buy	2,063	$7.89	$16,277.07	212,694
3/10/2025	Buy	3,360	$7.68	$25,804.80	210,852
3/26/2024	Buy	1,000	$8.13	$8,130.00	210,631
3/19/2024	Buy	647	$8.15	$5,273.05	209,631
12/1/2023	Buy	800	$7.80	$6,240.00	162,492
11/9/2023	Buy	401	$7.85	$3,147.85	160,607
4/16/2021	Buy	4,200	$10.33	$43,386.00	158,206
3/21/2019	Buy	1,200	$12.35	$14,820.00	153,406
3/15/2018	Sell	20,800	$16.40	$341,120.00	152,806
10/17/2017	Buy	202	$4.95	$999.90	172,646
10/12/2017	Buy	49	$4.95	$242.55	172,646
8/25/2017	Buy	400	$5.60	$2,240.00	172,797
5/19/2017	Buy	212	$6.72	$1,424.64	172,597
5/11/2017	Buy	302	$8.50	$2,567.00	172,385
4/15/2016	Buy	300	$8.06	$2,418.00	57,983
4/14/2016	Buy	200	$8.07	$1,614.00	16,083
4/11/2016	Buy	200	$8.06	$1,612.00	15,883
4/7/2016	Buy	100	$8.08	$808.00	15,683
1/15/2015	Buy	1,200	$6.27	$7,524.00
11/26/2014	Buy	1,300	$6.09	$7,917.00

Michael Richard Feldschuh Buying and Selling Activity at Daxor

Daxor Company Overview

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Today's Range

Now: $11.35

$11.00

$11.61

50 Day Range

MA: $10.54

$9.67

$11.72

2 Week Range

Now: $11.35

$8.56

$14.76

Volume

18,101 shs

Average Volume

40,892 shs

Market Capitalization

$66.25 million

P/E Ratio

N/A

Dividend Yield